8.14
price down icon2.98%   -0.25
after-market Dopo l'orario di chiusura: 8.21 0.07 +0.86%
loading
Precedente Chiudi:
$8.39
Aprire:
$8.5
Volume 24 ore:
30,231
Relative Volume:
0.05
Capitalizzazione di mercato:
$10.79M
Reddito:
$1.47M
Utile/perdita netta:
$-97.61M
Rapporto P/E:
-5.4631
EPS:
-1.49
Flusso di cassa netto:
$-80.90M
1 W Prestazione:
-4.80%
1M Prestazione:
-36.70%
6M Prestazione:
-13.22%
1 anno Prestazione:
-43.92%
Intervallo 1D:
Value
$7.7699
$8.50
Intervallo di 1 settimana:
Value
$7.7699
$8.6699
Portata 52W:
Value
$3.8101
$37.50

Lyra Therapeutics Inc Stock (LYRA) Company Profile

Name
Nome
Lyra Therapeutics Inc
Name
Telefono
617-373-4600
Name
Indirizzo
480 ARSENAL WAY, WATERTOWN, MA
Name
Dipendente
30
Name
Cinguettio
@LyraTx
Name
Prossima data di guadagno
2025-03-12
Name
Ultimi documenti SEC
Name
LYRA's Discussions on Twitter

Confronta LYRA con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
LYRA
Lyra Therapeutics Inc
8.14 13.11M 1.47M -97.61M -80.90M -1.49
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Lyra Therapeutics Inc Stock (LYRA) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-05-07 Downgrade BofA Securities Buy → Underperform
2024-05-07 Downgrade H.C. Wainwright Buy → Neutral
2024-05-07 Downgrade Jefferies Buy → Hold
2024-05-06 Downgrade William Blair Outperform → Mkt Perform
2023-10-06 Ripresa BTIG Research Buy
2023-08-31 Iniziato H.C. Wainwright Buy
2022-05-24 Iniziato Cantor Fitzgerald Overweight
2020-05-26 Iniziato BTIG Research Buy
2020-05-26 Iniziato BofA/Merrill Buy
2020-05-26 Iniziato Jefferies Buy
2020-05-26 Iniziato William Blair Outperform
Mostra tutto

Lyra Therapeutics Inc Borsa (LYRA) Ultime notizie

pulisher
Jul 24, 2025

How high can Lyra Therapeutics Inc. stock price go in 2025Free Bull & Bear Market Updates - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 23, 2025

Is Lyra Therapeutics Inc. a good long term investmentUnstoppable trading performance - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Lyra Therapeutics Inc. Stock Analysis and ForecastRobust investment performance - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about Lyra Therapeutics Inc. stockRobust financial gains - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

What drives Lyra Therapeutics Inc. stock priceExponential wealth increase - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Lyra Therapeutics (LYRA) Proposes Sale of 846,744 Shares of Comm - GuruFocus

Jul 22, 2025
pulisher
Jul 16, 2025

How Lyra Therapeutics Inc. stock performs during market volatilityFree Predictions - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

Why Lyra Therapeutics Inc. stock attracts strong analyst attentionConsistent High Return Strategy - beatles.ru

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Lyra Therapeutics Inc. stock price move sharplyFree Stock Market Courses - Newser

Jul 15, 2025
pulisher
Jul 14, 2025

Lyra Therapeutics CFO Cavalier sells $6k in shares By Investing.com - Investing.com Canada

Jul 14, 2025
pulisher
Jul 14, 2025

Lyra Therapeutics CEO Palasis sells $13944 in stock By Investing.com - Investing.com Nigeria

Jul 14, 2025
pulisher
Jul 14, 2025

Lyra Therapeutics CEO Palasis sells $13944 in stock - Investing.com

Jul 14, 2025
pulisher
Jul 13, 2025

Lyra Therapeutics (NASDAQ:LYRA) Downgraded to Sell Rating by Wall Street Zen - Defense World

Jul 13, 2025
pulisher
Jul 05, 2025

Lyra Therapeutics (NASDAQ:LYRA) Stock Rating Upgraded by Wall Street Zen - Defense World

Jul 05, 2025
pulisher
Jun 27, 2025

Lyra Therapeutics Announces Up to Approximately $15 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules - The Manila Times

Jun 27, 2025
pulisher
Jun 26, 2025

Lyra Therapeutics Secures $4.3M in Direct Offering - TipRanks

Jun 26, 2025
pulisher
Jun 25, 2025

Is Lyra Therapeutics, Inc. overvalued or undervalued? - MarketsMojo

Jun 25, 2025
pulisher
Jun 23, 2025

Lyra Therapeutics regains Nasdaq compliance as stock maintains $1 minimum - Investing.com UK

Jun 23, 2025
pulisher
Jun 16, 2025

Lyra Therapeutics: Regulatory Pathway For Non-Polyp Patients, An Underappreciated Catalyst - Seeking Alpha

Jun 16, 2025
pulisher
Jun 14, 2025

Lyra Therapeutics, Inc. (NASDAQ:LYRA) Stake Lessened by Two Sigma Investments LP - Defense World

Jun 14, 2025
pulisher
Jun 13, 2025

HC Wainwright Expects Higher Earnings for Lyra Therapeutics - Defense World

Jun 13, 2025
pulisher
Jun 12, 2025

Lyra Therapeutics (LYRA) Upgraded to Buy: Here's Why - sharewise

Jun 12, 2025
pulisher
Jun 10, 2025

H.C. Wainwright lifts Lyra Therapeutics stock target to $16 By Investing.com - Investing.com Canada

Jun 10, 2025
pulisher
Jun 10, 2025

Lyra Therapeutics (LYRA) Price Target Raised by HC Wainwright & Co. | LYRA Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

H.C. Wainwright Ups Target Price for Lyra Therapeutics (LYRA) to $16 | LYRA Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 09, 2025

Lyra Therapeutics, Inc. (NASDAQ:LYRA) Shares Sold by Two Sigma Advisers LP - Defense World

Jun 09, 2025
pulisher
Jun 09, 2025

Pre-market Movers: KLTO, TPST, PYPD, MOVE... - RTTNews

Jun 09, 2025
pulisher
Jun 07, 2025

Lyra Stock Soars 356% in a Week on Strong Rhinosinusitis Study Success - MSN

Jun 07, 2025
pulisher
Jun 06, 2025

Lyra Eyes US Filing For LYR-210 After Surprise ENLIGHTEN 2 Win - insights.citeline.com

Jun 06, 2025

Lyra Therapeutics Inc Azioni (LYRA) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):